Sera Prognostics (SERA) Cash from Investing Activities (2020 - 2026)

Sera Prognostics (SERA) posted Cash from Investing Activities of $9.0 million for Q1 2026, up 52.55% on a QoQ basis from $5.9 million in Q4 2025, and up 120.05% year-over-year from $4.1 million in Q1 2025.

Sera Prognostics (SERA) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Sera Prognostics' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at $9.0 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 120.05% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.3 million (up 192.38% YoY) and the FY2025 annual result came in at -$28.5 million, down 342.71% from the prior year.
  • Cash from Investing Activities was $9.0 million for Q1 2026 at Sera Prognostics, up from $5.9 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $14.6 million in Q1 2022 and bottomed at -$44.8 million in Q1 2025.
  • A 5-year average of -$105000.0 and a median of $4.9 million in 2024 frame the typical range for Cash from Investing Activities.
  • Peak annual rise in Cash from Investing Activities reached 35792.68% in 2022, while the deepest fall reached 1322.35% in 2022.
  • Sera Prognostics' Cash from Investing Activities stood at -$1.6 million in 2022, then soared by 123.7% to $374000.0 in 2023, then surged by 1874.6% to $7.4 million in 2024, then slipped by 20.24% to $5.9 million in 2025, then surged by 52.55% to $9.0 million in 2026.
  • Business Quant data shows SERA's Cash from Investing Activities at $9.0 million in Q1 2026, $5.9 million in Q4 2025, and $5.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.00 Bn 175.71 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.69 Bn 125.81 Bn 3.81 Bn -185.00 Mn
3 Medtronic 108.82 Bn 99.60 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.39 Bn 66.93 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 47.97 Bn 44.30 Bn 1.29 Bn -92.80 Mn
6 GE HealthCare Technologies 28.29 Bn 26.00 Bn 1.98 Bn -2.50 Bn
7 Dexcom 28.21 Bn 27.09 Bn 750.30 Mn -298.50 Mn
8 Smith & Nephew 26.91 Bn 26.33 Bn - -
9 Koninklijke Philips 25.45 Bn 22.32 Bn 2.07 Bn -475.32 Mn
10 Sera Prognostics 102.28 Mn 102.28 Mn -28,000.00 8.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.99 Mn
Mar 31, 2026 8.99 Mn
Dec 31, 2025 5.89 Mn
Dec 31, 2025 5.89 Mn
Sep 30, 2025 5.17 Mn
Sep 30, 2025 5.17 Mn
Jun 30, 2025 5.24 Mn
Jun 30, 2025 5.24 Mn
Mar 31, 2025 -44.80 Mn
Mar 31, 2025 -44.80 Mn
Dec 31, 2024 7.39 Mn
Dec 31, 2024 7.39 Mn
Sep 30, 2024 4.90 Mn
Sep 30, 2024 4.90 Mn
Jun 30, 2024 5.15 Mn
Jun 30, 2024 5.15 Mn
Mar 31, 2024 -5.69 Mn
Mar 31, 2024 -5.69 Mn
Dec 31, 2023 374,000.00
Dec 31, 2023 374,000.00